TY - JOUR
T1 - Scleromyxedema, a therapeutic dilemma
AU - Salas-Alanis, Julio Cesar
AU - Martinez-Jaramillo, Brayant
AU - Gomez-Flores, Minerva
AU - Ocampo-Candiani, Jorge
PY - 2015/4/1
Y1 - 2015/4/1
N2 - Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.
AB - Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement.
UR - http://www.scopus.com/inward/record.url?scp=84925402645&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925402645&partnerID=8YFLogxK
U2 - 10.4103/0019-5154.152600
DO - 10.4103/0019-5154.152600
M3 - Article
C2 - 25814746
SN - 0019-5154
VL - 60
SP - 215
JO - Indian Journal of Dermatology
JF - Indian Journal of Dermatology
IS - 2
ER -